Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 10, 2020
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
Qi Xiong, Ziwei Huang, Lingli Xin, et al.
Medicine
|
June 17, 2020
Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
Lupeng Qiu, Xiao Zhao, Weiwei Shi, et al.
Translational Lung Cancer Research
|
December 13, 2024
STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway
Xiangwei Ge, Qiaowei Liu, Hao Fan, et al.
BMC Cancer
|
June 16, 2023
Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters
Guhe Jia, Lupeng Qiu, Hongye Zheng, et al.
Journal of Invertebrate Pathology
|
September 5, 2025
The smell of Panulirus argus virus 1 (PaV1) infection: Disease-induced changes in metabolites in urine and hemolymph of Caribbean spiny lobsters Panulirus argus
Boyu Qin, Donald Behringer, Abigail K Scro, et al.
Frontiers in Oncology
|
June 7, 2022
Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity
Ruiguan Wang, Jiangbo Li, Changjian Zhang, et al.
Frontiers in Immunology
|
January 6, 2023
Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling
Liangliang Meng, Zhenjun Wang, Zhonghui Hou, et al.
Frontiers in Immunology
|
October 29, 2025
Correction: Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling
Liangliang Meng, Zhenjun Wang, Zhonghui Hou, et al.
BMC Cancer
|
January 17, 2024
Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study
Boyu Qin, Lingli Xin, Chen Liang, et al.
Cancer Innovation
|
July 1, 2024
Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study
Boyu Qin, Qi Xiong, Lingli Xin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Cancer Immunology, Immunotherapy : CII
|
September 10, 2020
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
Qi Xiong, Ziwei Huang, Lingli Xin, et al.
Medicine
|
June 17, 2020
Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
Lupeng Qiu, Xiao Zhao, Weiwei Shi, et al.
Translational Lung Cancer Research
|
December 13, 2024
STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway
Xiangwei Ge, Qiaowei Liu, Hao Fan, et al.
BMC Cancer
|
June 16, 2023
Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters
Guhe Jia, Lupeng Qiu, Hongye Zheng, et al.
Journal of Invertebrate Pathology
|
September 5, 2025
The smell of Panulirus argus virus 1 (PaV1) infection: Disease-induced changes in metabolites in urine and hemolymph of Caribbean spiny lobsters Panulirus argus
Boyu Qin, Donald Behringer, Abigail K Scro, et al.
Frontiers in Oncology
|
June 7, 2022
Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity
Ruiguan Wang, Jiangbo Li, Changjian Zhang, et al.
Frontiers in Immunology
|
January 6, 2023
Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling
Liangliang Meng, Zhenjun Wang, Zhonghui Hou, et al.
Frontiers in Immunology
|
October 29, 2025
Correction: Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling
Liangliang Meng, Zhenjun Wang, Zhonghui Hou, et al.
BMC Cancer
|
January 17, 2024
Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study
Boyu Qin, Lingli Xin, Chen Liang, et al.
Cancer Innovation
|
July 1, 2024
Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study
Boyu Qin, Qi Xiong, Lingli Xin, et al.
Page
of 4